Medicare Enrolled
Dr. Ann-Margaret Ochs, D. O.
Hematology & Oncology · Weatherford, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ochs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ochs?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ochs
Dr. Ann-Margaret Ochs is a hematology & oncology specialist in Weatherford, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ochs performed 132,256 Medicare services across 3,025 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ochs received a total of $897 from 23 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ochs is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in TX
$897 industry payments
Medicare Practice Summary
Medicare Utilization ↗132,256
Medicare services
Top 4% in TX for hematology & oncology
3,025
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,961 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
57,120 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 22,900 | $43 | $137 |
| Paclitaxel chemotherapy injection | 10,536 | $0 | $8 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,350 | $0 | $5 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
9,138 | $34 | $234 |
| Denosumab injection (Prolia/Xgeva) | 8,700 | $18 | $66 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,830 | $6 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,825 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,150 | $1 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
901 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
770 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 710 | $0 | $24 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
493 | $22 | $157 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
489 | $2 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
467 | $97 | $707 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
444 | $47 | $313 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
426 | $93 | $368 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
420 | $10 | $64 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
367 | $10 | $96 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
284 | $6 | $431 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
261 | $14 | $43 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
233 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $61 | $250 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
175 | $15 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
152 | $21 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
127 | $48 | $344 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
124 | $6 | $31 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
123 | $11 | $108 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 109 | $134 | $3,675 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
104 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
104 | $6 | $34 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
93 | $2 | $19 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
86 | $7 | $29 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
86 | $1 | $8 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
84 | $1 | $6 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
70 | $13 | $60 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
69 | $24 | $256 |
| Iron level test | 68 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
68 | $9 | $35 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $24 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $121 | $565 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
57 | $18 | $114 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
48 | $8 | $49 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
46 | $4 | $25 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
43 | $1 | $19 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
38 | $9 | $56 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
37 | $1,141 | $4,802 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $133 | $496 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 35 | $90 | $657 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
30 | $61 | $264 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
25 | $10 | $75 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
21 | $19 | $99 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $61 | $372 |
| New patient office visit, complex (60-74 min) | 11 | $168 | $709 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.5% high complexity
45.4% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$897
Total received (2018-2024)
Avg $149/year across 6 years
Bottom 27% in TX for hematology & oncology
23
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$862 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$235
2023
$209
2022
$111
2021
$12
2019
$51
2018
$280
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$118
Novartis Pharmaceuticals Corporation
$80
Stryker Corporation
$70
Celgene Corporation
$64
AstraZeneca Pharmaceuticals LP
$57
Puma Biotechnology, Inc.
$53
GENZYME CORPORATION
$46
PFIZER INC.
$43
Monteris Medical Corporation
$35
Janssen Biotech, Inc.
$31
Genentech USA, Inc.
$31
ABBVIE INC.
$27
Astellas Pharma US Inc
$27
EISAI INC.
$24
E.R. Squibb & Sons, L.L.C.
$23
Gilead Sciences, Inc.
$23
Karyopharm Therapeutics Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
Lilly USA, LLC
$22
GlaxoSmithKline, LLC.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Pharmacyclics LLC, An AbbVie Company
$20
Merck Sharp & Dohme Corporation
$15
Top 3 companies account for 29.9% of total payments
Associated products mentioned in payments ›
Avastin · BOSULIF · DARZALEX · Empaveli · Erleada · Fabhalta · IMBRUVICA · JAYPIRCA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lenvima · NERLYNX · Nerlynx · Neuroblate · OJJAARA · OPTABLATE · REBLOZYL · SARCLISA · SUTENT · TECENTRIQ · VENCLEXTA · VOTRIENT · Vyloy · XALKORI · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
5
Per 100K population
3.2
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ochs is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ochs experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ochs performed 57,120 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ochs receive payments from pharmaceutical companies?
Yes. Dr. Ochs received a total of $897 from 23 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ochs's costs compare to other hematology & oncology specialists in Weatherford?
Dr. Ochs's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ochs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Weatherford
Browse hematology & oncology specialists in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology